4//SEC Filing
Cortis Christian 4
Accession 0001415889-24-017954
CIK 0001681087other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:16 PM ET
Size
11.7 KB
Accession
0001415889-24-017954
Insider Transaction Report
Form 4
Cortis Christian
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-06-20+18,704→ 18,704 totalExercise: $5.38Exp: 2033-11-30→ Common Stock (18,704 underlying) - Award
Employee Stock Option (Right to Buy)
2024-06-20+56,061→ 56,061 totalExercise: $2.38Exp: 2031-06-27→ Common Stock (56,061 underlying) - Award
Common Stock
2024-06-20+126,368→ 126,368 total
Footnotes (6)
- [F1]Received in exchange for 236,458 shares of common stock of Tectonic Therapeutic, Inc., a Delaware corporation ("Tectonic"), pursuant to an Agreement and Plan of Merger dated as of January 30, 2024 (the "Merger Agreement") by and among AVROBIO, Inc., a Delaware corporation ("AVROBIO"), Tectonic and Alpine Merger Subsidiary, Inc., a direct, wholly owned subsidiary of AVROBIO (the "Merger Sub"). Under the terms of the Merger Agreement, on June 20, 2024, Merger Sub merged with and into Tectonic (the "Merger"), with Tectonic surviving the Merger as a wholly owned subsidiary of AVROBIO. Upon the closing of the Merger, each share of Tectonic common stock was converted into the right to receive 0.534419990 shares of the Issuer's common stock, after giving effect to a reverse stock split of the Issuer's common stock of 1-for-12. Subsequent to the Merger, the name of the Issuer was changed from AVROBIO, Inc. to Tectonic Therapeutic, Inc.
- [F2]Upon the closing of the Merger, each outstanding option to purchase shares of Tectonic common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock, on the same terms and conditions as were applicable to such Tectonic stock option prior to the Merger, as adjusted for the exchange ratio and the reverse stock split.
- [F3]22,508 shares subject to the option are fully vested. The remaining shares subject to the option vest in 10 equal monthly installments beginning on June 30, 2024, such that the option will be fully vested on March 31, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F4]Received in exchange for a stock option to acquire 104,901 shares of Tectonic common stock pursuant to the Merger Agreement.
- [F5]The shares subject to the option vest in 48 equal monthly installments beginning on December 1, 2023, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F6]Received in exchange for a stock option to acquire 35,000 shares of Tectonic common stock pursuant to the Merger Agreement.
Documents
Issuer
Tectonic Therapeutic, Inc.
CIK 0001681087
Entity typeother
Related Parties
1- filerCIK 0001744495
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:16 PM ET
- Size
- 11.7 KB